Ruxolitinib as salvage therapy for neonatal <scp>HLH</scp> in preterm twins born to a mother with adult‐onset Still's disease

The authors declare no conflict of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.

Authors

Institutions

Publication Details

Journal
Pediatrics International
Published
2025-01-01
DOI
https://doi.org/10.1111/ped.70203
Primary Topic
Autoimmune and Inflammatory Disorders Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ruxolitinib as salvage therapy for neonatal HLH in preterm twins born to a mother with adult‐onset Still's disease

Y. Maruyama, Masaki Shimizu, Maho Hatano, Yozo Nakazawa et al.
Pediatrics International
Autoimmune and Inflammatory Disorders Research
article

Ruxolitinib as salvage therapy for neonatal HLH in preterm twins born to a mother with adult‐onset Still's disease

Y. Maruyama, Masaki Shimizu, Maho Hatano, Yozo Nakazawa, Yukihide Miyosawa, Motoko Kamiya, Cristiane Yoshie Nakazawa
article en

Abstract

The authors declare no conflict of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.

Pediatrics InternationalVol. 67(1)
Shinshu University (JP), Institute of Developmental Physiology (RU), Shinshu University Hospital (JP)
Openalex Percentile: Top 68%
Autoimmune and Inflammatory Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.